Noticias de SNY_US

Noticias del mercado

Últimas noticias sobre SNY_US — 310 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNY_US ✕ 310 resultados
21/04/2026 SNY_US — TipRanks ES ← EN
El ensayo Lunsekimig de Sanofi alcanza un hito clave en la cartera de dermatitis atópica
21/04/2026 SNY_US — The Indian Practitioner ES ← EN
Nuvaxovid supera a la vacuna de ARNm en tolerabilidad, informa Sanofi
21/04/2026 SNY_US — TradingView ES ← EN
Se espera que Sanofi SA registre ganancias de 1,03 dólares por acción - Vista previa de ganancias
21/04/2026 SNY_US — Yahoo Finance
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
21/04/2026 SNY_US — Yahoo Finance
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
20/04/2026 SNY_US — Seeking Alpha ES ← EN
Qué esperar de Sanofi en el primer trimestre de 2026 (NASDAQ:SNY)

What To Expect From Sanofi In Q1 2026 (NASDAQ:SNY)

20/04/2026 SNY_US — The Pharma Letter ES ← EN
La vacuna Nuvaxovid COVID-19 de Sanofi supera la tolerabilidad de mNEXSPIKE

Sanofi's Nuvaxovid COVID-19 vaccine bests tolerability of mNEXSPIKE

20/04/2026 SNY_US — Fierce Pharma
Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
20/04/2026 SNY_US — Yahoo Finance
Is Sanofi (SNY) One of the Best Affordable Blue Chip Stocks to Buy Now?
20/04/2026 SNY_US — MarketScreener ES ← EN
Un estudio muestra que Nuvaxovid de Sanofi se tolera mejor que mNEXSPIKE de Moderna
18/04/2026 SNY_US — MarketScreener ES ← EN
La vacuna Nuvaxovid Covid-19 de Sanofi mostró una mejor tolerabilidad que Mnexspike en un estudio comparativo
18/04/2026 SNY_US — Yahoo Finance ES ← EN
Comunicado de prensa: ESCMID: La vacuna Nuvaxovid COVID-19 de Sanofi mostró una mejor tolerabilidad que mNEXSPIKE en un estudio comparativo
18/04/2026 SNY_US — Yahoo Finance
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
17/04/2026 SNY_US — PETA
Sanofi Urged to Probe Studies Using Monkeys From Filthy Lab After PETA Exposé
16/04/2026 SNY_US — Medical Marketing and Media
The Escalator: Sanofi, Merck, Novo Nordisk and more
16/04/2026 SNY_US — Yahoo Finance
Sanofi Expands Immunology Footprint With New Approvals And Respiratory Data
15/04/2026 SNY_US — Oncology Pipeline
Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis
14/04/2026 SNY_US — GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares - March 2026
13/04/2026 SNY_US — Fox Business
Merck, Sanofi are latest companies to add medications to TrumpRx
12/04/2026 SNY_US — Yahoo Finance
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Página 13 de 16

keyboard_arrow_up